Fetal Fentanyl Syndrome: Unveiling a New Syndrome Linked to Fentanyl Use During Pregnancy
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
July 8, 2021
The article describes how FDNA is expediting the diagnosis of common genetic disorders in children. Using advanced AI technology, their Face2Gene tool analyzes facial features to identify genetic anomalies. FDNA makes diagnostic consultations more accessible, particularly for underserved or remote areas. The platform allows photos to be uploaded for analysis, providing quick and accurate diagnostic suggestions. This approach improves early diagnosis and personalized treatment plans. FDNA’s innovative solutions significantly advance the identification and management of genetic disorders in children, leading to better patient outcomes.
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
Dr Giulia Pascolini, an esteemed Italian M.D. and Ph.D., is currently responsible for the Genetic Counselling Service of the Istituto…
Founded in 2017, the Spanish Coffin Siris Syndrome Association is an organization dedicated to supporting families affected by this rare…